News & Events

April 14, 2021

BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)

The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction CRESSKILL,...

March 24, 2021

BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights

Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET CRESSKILL, N.J. and JERUSALEM, Israel,...

March 23, 2021

(Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain

BrainsWay CEO Christopher von Jako discusses how Deep TMS is used to treat neurological conditions such...

March 11, 2021

BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

CRESSKILL, N.J., March 11, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...

March 8, 2021

BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference

CRESSKILL, N.J. and JERUSALEM, Israel, March 8, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

February 23, 2021

BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Feb. 23, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

February 22, 2021

BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Feb. 22, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

February 19, 2021

Practical Applications and Uses of Deep TMS for Treating Individuals with OCD

Commentary provided by Dr. Muir and Dr. Vidrine offers in-depth insight around Deep TMS as an effective,...

February 16, 2021

BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales

CRESSKILL, N.J. and JERUSALEM, Israel, February 16, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

February 16, 2021

BrainsWay Reports Preliminary Record Fourth Quarter Revenue and Full-Year 2020 Financial Results

CRESSKILL, N.J. and JERUSALEM, Israel, February 16, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

February 8, 2021

Rate of Depression Growing During COVID-19, BrainsWay CEO Discusses Importance and Effectiveness of Deep TMS Treatment

BrainsWay CEO Christopher von Jako outlines the importance on how informing the public on Deep TMS as...

January 25, 2021

BrainsWay Signs Exclusive Distribution Agreement with Gaelan Medical Trade LLC

CRESSKILL, N.J. and JERUSALEM, Israel, Jan. 25, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

December 30, 2020

VeryWell Mind Discusses the Key Pillars of Maintaining Mental Health

VeryWell Mind, a mental health and wellness news resource for consumers, provides tips for improving...